Dr. Ali S. Faqi and Leading Scientists Author Ground-Breaking Toxicology Book from Elsevier
New reference work addresses need for guide to preclinical toxicology research
San Antonio, TX, March 11, 2013 –Elsevier, a world-leading provider of scientific, technical and medical information products and services, and MPI Research, the largest single-site preclinical contract research organization worldwide, today announced the launch of A Comprehensive Guide to Toxicology in Preclinical Drug Development, a new reference work edited by Dr. Ali Said Faqi, Senior Director of Developmental and Reproductive Toxicology at MPI Research. The book will be featured at the Society of Toxicology’s ToxExpo, March 10-14, 2013.
Addressing the unmet need for a detailed guide to preclinical toxicology research, the book guides scientists through the critically important and rapidly evolving process of answering the question: is a drug safe for patients? A Comprehensive Guide to Toxicology in Preclinical Drug Development is unique because it combines preclinical development for both small and large molecules and covers emerging technology and methods. For the first time, a reference brings this material together with information on vaccines, worldwide regulatory considerations (including Chinese regulations), and other emerging areas to help scientists understand and predict toxicity.
The book will benefit students as they begin work in preclinical environments in either private industry or academia. It also provides practicing toxicologists, new clinicians and regulatory professionals with a comprehensive reference manual on the practical aspects of preclinical work.
A Comprehensive Guide to Toxicology in Preclinical Drug Development, with contributions from 79 leading scientists, covers the latest in vitro, in vivo and technological advances in use today, from investigative toxicology to the evaluation of toxicity and pharmacologic effects of a new chemical entity. Chapter highlights include absorption, distribution, metabolism, excretion (ADME), acute sub-chronic and chronic toxicity testing, toxicogenomics, developmental and reproductive toxicology, carcinogenicity testing, histopathology, imaging, immunotoxicity, and other relevant topics.
The book, published by Elsevier under the Academic Press imprint, is available electronically and in print and can be purchased on the Elsevier Store, as well as on ScienceDirect.
# # #
Note for Editors
Full details of the book: A Comprehensive Guide to Toxicology in Preclinical Drug Development by Ali S. Faqi, ISBN: 9780123878151, Academic Press.
Copies of the book are available to credentialed journalists upon request; contact Michelle McMahon at +1 781 663 2268 or firstname.lastname@example.org to request a review copy or to schedule an interview with the author.
About the Editor
Ali Said Faqi, DVM, PhD, DABT, Fellow, ATS, is the Senior Director of Developmental and Reproductive Toxicology and a Senior Principal Scientist at MPI Research. He is also an Adjunct Associate Professor at Wayne State University, School of Medicine. Before joining MPI Research, Dr. Faqi was a Senior Scientist at Allergan Pharmaceuticals and Research Toxicologist at IIT Research Institute. He received his PhD from the University of Leipzig in Germany, DVM from Somali National University, and earned a diploma of specialization in Experimental Pharmacology from the University of Milan. He was a postdoctoral Fellow at the Institute of Clinical Pharmacology and Toxicology at the Free University of Berlin-Germany, a Diplomate of American Board of Toxicology (DABT) and a Fellow of the Academy Toxicological Sciences (ATS). Dr. Faqi is a member of the Editorial Boards of Reproductive Toxicology and ISRN Toxicology. He is also a member of the Scientific Advisory Board of the Alzheimer's Art Quilt Initiative (AAQI). Dr. Faqi previously served on the Board of Scientific Counselors (BOSC) Computational Toxicology at the United States Environmental Protection Agency. He is an ad hoc scientific reviewer for several scientific journals, published extensively in the field of developmental and reproductive toxicology, and has won multiple publishing awards.
About MPI Research
MPI Research, with global headquarters in Michigan, provides discovery, safety evaluation, and bioanalytical and analytical testing services (formulation development, regulated bioanalysis, immunochemistry, metals analysis, and environmental analysis) to the biopharmaceutical, medical device, animal health, agricultural, environmental, and chemical industries. Scientific knowledge and experience, quick turnaround, and dedication to strong and enduring Sponsor relationships characterize MPI Research as a high-performance, high-quality organization committed to bringing safer and more effective products to the world. Learn more about how we can go beyond your expectations at www.mpiresearch.com.
Elsevier is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com